您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:泰和诚医疗2015年度报告 - 发现报告
当前位置:首页/财报/招股书/报告详情/

泰和诚医疗2015年度报告

2016-04-28美股财报小***
泰和诚医疗2015年度报告

20-F 1 v436874_20f.htm FORM 20-F UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 20-F (Mark One)Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934 or Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2015 or Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to or Shell company report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of event requiring this shell company report Commission file number 001-34563 Concord Medical Services Holdings Limited(Exact Name of Registrant as Specified in Its Charter) Cayman Islands(Jurisdiction of Incorporation or Organization) 18/F, Tower A, Global Trade Center36 North Third Ring Road, Dongcheng DistrictBeijing 100013People’s Republic of China(Address of Principal Executive Offices) Mr. Adam Jigang SunTelephone: (86 10) 5957-5266Facsimile: (86 10) 5957-525218/F, Tower A, Global Trade Center 36 North Third Ring Road, Dongcheng DistrictBeijing 100013People’s Republic of China(Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of Each ClassClass A ordinary shares, par value US$0.0001 per share*Name of Each Exchange on Which RegisteredNew York Stock Exchange* *Not for trading, but only in connection with the listing of the American depositary shares, or ADSs, on the New York Stock Exchange. Each ADS represents the right to receive three Class A ordinary shares. The ADSs are registered under the Securities Act of 1933, as amended, pursuant to a registration statement on Form F-6. Accordingly, the ADSs are exempt from registration under Section 12(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 12a-8 thereunder. Securities registered or to be registered pursuant to Section 12(g) of the Act: None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None Indicate the number of outstanding shares of each of the Issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 132,994,201 Class A Ordinary Shares Issued and Outstanding Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No  If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes  No  Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer Accelerated filer Non-accelerated filer  Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing: U.S. GAAP International Financial Reporting Standards as issued by the International Accounting Standards Board Other  If “Other” has been checked in response to the previous question, indicate by check mark which consolidated financial statement item the registrant has elected to follow. Item 17  Item 18  If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Yes  No  (APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS) Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes  No  TABLE OF CONTENTS Page PART I 2 ITEM 1.IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS2 ITEM 2.OFFER STATISTICS AND EXPECTED TIMETABLE2 ITEM 3.KEY INFORMATION2 ITEM 4.INFORMATION ON THE COMPANY32 ITEM 4A.UNRESOLVED

你可能感兴趣

hot

泰和诚医疗2022年度报告

美股财报2023-04-19
hot

泰和诚医疗2020年度报告

美股财报2021-10-15
hot

泰和诚医疗2013年度报告

美股财报2014-04-28
hot

泰和诚医疗2021年度报告

美股财报2022-04-29
hot

泰和诚医疗2019年度报告

美股财报2020-04-30